Galectin‐3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients

BACKGROUND: Obesity is a precursor to heart failure with preserved ejection fraction. Biomarkers that identify preclinical metabolic heart disease (MHD) in young obese patients would help identify high‐risk individuals for heart failure prevention strategies. We assessed the predictive value of GAL3...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Am Heart Assoc
Päätekijät: Gopal, Deepa M., Ayalon, Nir, Wang, Yi‐Chih, Siwik, Deborah, Sverdlov, Aaron, Donohue, Courtney, Perez, Alejandro, Downing, Jill, Apovian, Caroline, Silva, Vanessa, Panagia, Marcello, Kolachalama, Vijaya, Ho, Jennifer E., Liang, Chang‐seng, Gokce, Noyan, Colucci, Wilson S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509711/
https://ncbi.nlm.nih.gov/pubmed/30929550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.011100
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia